CN114681135A - Heart valve prosthesis - Google Patents
Heart valve prosthesis Download PDFInfo
- Publication number
- CN114681135A CN114681135A CN202011611922.8A CN202011611922A CN114681135A CN 114681135 A CN114681135 A CN 114681135A CN 202011611922 A CN202011611922 A CN 202011611922A CN 114681135 A CN114681135 A CN 114681135A
- Authority
- CN
- China
- Prior art keywords
- leaflet
- heart valve
- valve prosthesis
- row
- holes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003709 heart valve Anatomy 0.000 title claims abstract description 82
- 230000000149 penetrating effect Effects 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims 3
- 230000001965 increasing effect Effects 0.000 abstract description 14
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 5
- 230000002861 ventricular Effects 0.000 description 5
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000018578 heart valve disease Diseases 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 210000004115 mitral valve Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- -1 especially Substances 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003102 pulmonary valve Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2463—Implants forming part of the valve leaflets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
The invention provides a heart valve prosthesis, which is applied to the technical field of interventional medical prostheses. In the heart valve prosthesis provided by the invention, under the condition that the sizes of the valve leaflet connecting parts are the same, compared with the condition that the closed holes are arranged on the valve leaflet fixing structure in the prior art, the valve leaflet connecting parts of the double-row hole structure with the structure that each row of holes at least comprises one non-closed hole are arranged in the support main body in the heart valve prosthesis, so that more suture holes which are more compactly distributed can be arranged on the valve leaflet fixing structure, the connecting points of the valve leaflets and the support are increased, the connecting strength of the valve leaflets and the support is enhanced under the condition that the outer diameter of the support is not increased after the support is compressed, and the stability of the heart valve prosthesis in a working state is further improved.
Description
Technical Field
The invention relates to the technical field of interventional medical prostheses, in particular to a heart valve prosthesis.
Background
The heart contains four chambers, the left atrium and left ventricle being located on the left side of the heart, and the right atrium and right ventricle being located on the right side of the heart. A ventricular inflow channel structure is formed between the atria and the ventricles, a left ventricular outflow channel structure is formed between the left ventricle and the aorta, and a right ventricular outflow channel structure is formed between the right ventricle and the pulmonary artery. Valves with the function of 'one-way valves' exist at the ventricular inflow canal structure and the ventricular outflow canal structure, and normal flow of blood in the heart cavity is guaranteed. When a problem occurs with the valve, the hemodynamics of the heart change and the heart functions abnormally, which is called valvular heart disease.
With the increase of human life and the aging of human population, the incidence of valvular heart disease is higher and higher. According to literature statistics, valvular disease exists in 2-7% of the elderly aged over 65 years old. Prosthetic Heart valves (Heart Valve prostheses) are artificial organs that can be implanted in the Heart to replace Heart valves (including aortic, pulmonary, tricuspid and mitral valves), allow unidirectional blood flow, and function as native Heart valves. Prosthetic heart valve replacement is necessary when the heart valve is so diseased that a valve separation or repair procedure cannot be used to restore or improve valve function. The design of interventional heart valves is difficult due to the complexity of their replacement. For example, in practical applications, prosthetic heart valves have certain requirements on the contact area of the valve leaflets after closure and the stability of the connection of the leaflets to the stent.
However, in the prior art, the mechanical property of the stent of the artificial heart valve for interventional operation is relatively poor, which affects the connection between the valve leaflet and the stent and causes the defect of poor connection stability between the valve leaflet and the stent, so that the valve displacement is easy to occur under the impact action of blood in the normal operation process of the lesion position of the artificial heart valve in the human body, and thus, when the heart valve is in a closed state, the contact area of the valve leaflet is insufficient, and the failure of the artificial heart valve prosthesis is caused under the serious condition. Further, for a transcatheter heart valve system, the valve stent is compressed into a sheath of a delivery system, and the delivery of the valve stent is achieved by axial movement of the sheath, so that the compressed outer diameter (profile) of the valve stent needs to be slightly smaller than the inner diameter of the sheath. And if the number of the connecting holes of the valve leaflet and the support in the prior art is increased, the outer diameter (profile) of the valve support after being compressed is increased. Therefore, how to enhance the connection strength between the leaflet and the stent without increasing the outer diameter (profile) of the valve stent after compression is a problem to be solved.
Disclosure of Invention
The invention aims to provide a heart valve prosthesis, which can be used for enhancing the connection strength between a valve leaflet and a support in the heart valve prosthesis under the condition that the outer diameter of the support in the heart valve prosthesis is not increased after compression.
In order to solve the technical problems, the invention provides a heart valve prosthesis, which comprises a stent main body and at least two valve leaflets connected to the stent main body, wherein the stent main body comprises grid-shaped structural units connected with each other from an inflow end to an outflow end, the stent main body further comprises a plurality of valve leaflet fixing structures, and each valve leaflet fixing structure comprises a support part and valve leaflet connecting parts positioned on two sides of the support part; the leaflet connecting component comprises a double-row hole structure, wherein each row of holes in the double-row hole structure at least comprises one non-closed hole.
Alternatively, the leaflet securing structure may be provided at the outflow end of the stent body, or on the outer surface along the circumference of the stent body.
Alternatively, a plurality of the leaflet connecting members may be uniformly arranged in the circumferential direction of the cross section of the stent body.
Optionally, when each row of holes in the double-row hole structure includes a plurality of non-closed holes, two rows of holes in the double-row hole structure may be symmetrically disposed along the central axis of the support member.
Optionally, the aperture size of each hole in the double-row hole structure in the axial direction is adapted to the contact height required by two adjacent valve leaflets in the axial direction, and/or the number of each row of holes in the double-row hole structure is adapted to the contact height required by two adjacent valve leaflets in the axial direction.
Optionally, the aperture of each hole in the double-row hole structure in the axial direction may range from 0.6mm to 2 mm.
Optionally, the number of each row of holes in the double-row hole structure may be 1-4.
Optionally, the number of leaflet securing structures is the same as the number of leaflets.
Optionally, when the leaflet fixing structure is disposed at the outflow end of the stent body, the leaflet fixing structure is inclined toward the axial direction of the stent body so that the leaflet fixing structure forms a predetermined angle with the central axis of the stent body.
Optionally, a value range of a preset angle formed by the leaflet fixing structure and the central axis of the stent main body is 0 to 15 °.
Alternatively, the coaptation region of two adjacent leaflets can be sutured to the leaflet connecting member to connect the leaflets to the stent body.
Optionally, when each of the holes of the leaflet-connecting member is a non-closed hole penetrating the leaflet-connecting member and having a notch at one side, a suture for suturing the bonding area of the adjacent two leaflets to the leaflet-connecting member is embedded in the notch of the leaflet-connecting member.
Compared with the prior art, the technical scheme of the invention has at least one of the following beneficial effects:
in the heart valve prosthesis provided by the invention, under the condition that the sizes of the valve leaflet connecting parts are the same, compared with the condition that the closed holes are arranged on the valve leaflet fixing structure in the prior art, the valve leaflet connecting parts of the double-row hole structure with the structure that each row of holes at least comprises one non-closed hole are arranged in the support main body in the heart valve prosthesis, so that more suture holes which are more compactly distributed can be arranged on the valve leaflet fixing structure, the connecting points of the valve leaflets and the support are increased, the connecting strength of the valve leaflets and the support is enhanced under the condition that the outer diameter of the support is not increased after the support is compressed, and the stability of the heart valve prosthesis in a working state is further improved.
Drawings
FIG. 1 is a schematic structural view of a heart valve prosthesis according to an embodiment of the present invention;
FIG. 2 is a front view of the corresponding heart valve prosthesis of FIG. 1;
FIG. 3 is a schematic diagram of the structure of valve leaflets in a heart valve stent according to an embodiment of the invention;
FIG. 4 is a schematic structural view of a heart valve stent according to an embodiment of the present invention;
fig. 5 is an enlarged schematic view of a leaflet securing structure in a heart valve stent according to an embodiment of the invention.
Wherein the reference numbers are as follows:
1-a heart valve stent; 2-skirt edge;
3-valve leaflets; 4-a binding region;
5-leaflet upper edge; 6-leaflet lower edge;
7-a suture; 11-inflow end;
12-the outflow end; 13-a leaflet securing structure;
131-leaflet connecting member; 132-support member.
Detailed Description
A heart valve prosthesis of the present invention will be described in further detail below. The present invention will now be described in more detail with reference to the accompanying drawings, in which preferred embodiments of the invention are shown, it being understood that one skilled in the art may modify the invention herein described while still achieving the advantageous effects of the invention. Accordingly, the following description should be construed as broadly as possible to those skilled in the art and not as limiting the invention.
In the interest of clarity, not all features of an actual implementation are described. In the following description, well-known functions are not described in detail, as they would obscure the invention in unnecessary detail. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific details must be set forth in order to achieve the developer's specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art.
Bearing as background art said, because in prior art, the mechanical properties of the artificial heart valve support of intervention operation is relatively poor, this can influence the connection of leaflet and support, cause the defect of the poor stability of being connected of leaflet and support, and then make artificial heart valve in the normal operating process of human internal pathological change position, easy emergence support deformation under the impact of blood, especially, lead to heart valve when closed state when leaflet and support combination department take place deformation, valve leaflet area of contact is not enough, cause the problem of artificial heart valve prosthesis inefficacy under the severe condition. Further, for a transcatheter heart valve system, the valve stent is compressed into a sheath of a delivery system, and the delivery of the valve stent is achieved by axial movement of the sheath, so that the compressed outer diameter (profile) of the valve stent needs to be slightly smaller than the inner diameter of the sheath. And if the number of the connecting holes of the valve leaflet and the support in the prior art is increased, the outer diameter (profile) of the valve support after being compressed is increased.
To this end, the present invention provides a heart valve prosthesis to enhance the coupling strength between leaflets and a stent in the heart valve prosthesis without an increase in outer diameter of the stent after compression in the heart valve prosthesis.
In practical applications, the side of the blood flowing into the prosthetic heart valve prosthesis is generally referred to as the inflow end of the heart valve stent, and the side of the blood flowing out of the prosthetic heart valve prosthesis is generally referred to as the outflow end of the heart valve stent, according to the flowing direction of the blood in the prosthetic heart valve prosthesis. It is understood that the inflow end and the outflow end are only used for identifying the flow direction of blood, and the specific position of each part in the prosthetic heart valve prosthesis is not particularly limited.
The axial direction refers to the direction of the rotation center of the cylinder-like object, which is the common direction with the central shaft, and in the embodiment of the present invention, the axial direction of the stent main body refers to the direction extending along the two ends of the inflow end and the outflow end of the stent main body.
The heart valve prosthesis provided by the invention is further described in the following with reference to the drawings and the embodiments.
Referring to fig. 1 and fig. 2, fig. 1 is a schematic structural diagram of a heart valve prosthesis according to an embodiment of the present invention, and fig. 2 is a front view of the heart valve prosthesis shown in fig. 1.
As shown in fig. 1 and 2, the heart valve prosthesis comprises a heart valve support 1, a skirt 2 and a heart valve, wherein the heart valve comprises at least two valve leaflets 3.
In this embodiment, the heart valve stent 1 is used to carry a prosthetic heart valve, which may typically comprise a plurality of leaflets 3 in order to match the actual condition of a human heart valve. In an embodiment of the present invention, as shown in fig. 3, each leaflet 3 may specifically include a leaflet lower edge 6 (for connecting the leaflet 3 with the skirt 2), a leaflet upper edge 5, and a joining region 4 (for fixing two adjacent leaflets 3). Among them, the coaptation region of adjacent leaflets 3 in a prosthetic heart valve can be referred to as the coaptation region 4 (comissure) of adjacent leaflets 3; also, the leaflets 3 may be attached to the stent 1 by the commissure regions 4, for example, by folding or wrapping the stent and then suturing the stent.
Referring to fig. 4, fig. 4 is a schematic structural view of the heart valve stent 1 shown in fig. 1 and 2. As shown in fig. 4, the heart valve stent includes a stent body including interconnected lattice-like structural units from an inflow end 11 to an outflow end 12. And, the stent main body further includes a plurality of leaflet fixing structures 13 for connecting the stent main body with the leaflets 3.
The stent main body can be made of shape memory alloy, and preferably, the stent main body is made of nickel titanium metal material.
In this embodiment, the inlet of the large-mouth end surface of the upper half of the lattice structure in fig. 4 is referred to as the inlet end 11 of the stent body, and the outlet of the small-mouth end surface of the lower half of the lattice structure is referred to as the outlet end 12 of the stent body. Illustratively, each of the leaflet securing structures 13 may be disposed at the outflow end 12 of the stent body such that the plurality of leaflet securing structures 13 are connected to the lattice structure, as shown in fig. 4. Preferably, the leaflet fixing structure 13 is inclined toward the axial direction of the stent body such that the leaflet fixing structure 13 forms a predetermined angle with the central axis of the stent body. The valve leaf fixing structure 13 and the central axis of the stent main body form a preset angle, and the value range of the preset angle is preferably 0-15 degrees. The valve leaflet fixing structure 13 can be better matched with the shape of the corresponding heart native tissue after being implanted, and the influence on the heart native tissue is reduced.
In the embodiment of the present invention, the leaflet fixing structure 13 is inclined toward the axial direction of the stent main body, so that on one hand, damage to native tissues of a heart portion of a human body can be avoided, and on the other hand, the leaflet fixing structure can be more adapted to the shape of the closed valve leaflets, so as to prolong the service life of the heart valve prosthesis.
Optionally, each leaflet fixing structure 13 may be further disposed on an outer surface along a circumferential direction of the stent body, that is, on an outer surface of a certain stent body between the inflow end and the outflow end of the stent body, so that the leaflet fixing structures 13 are matched with the shape of the valve leaflets, thereby reducing stress concentration, prolonging the service life of the suture, and finally prolonging the service life of the valve prosthesis. The leaflet securing structure 13 is preferably integrally formed with the stent body by laser cutting.
For clarity of description, the structure of the leaflet fixing structure 13 will be specifically described below by way of the following examples.
Referring to fig. 5, fig. 5 is an enlarged schematic structural view of a leaflet fixing structure 13 according to an embodiment of the invention. As shown in fig. 5, the leaflet fixing structure 13 includes a support member 132 and leaflet connecting members 131 located on both sides of the support member 132. Wherein the leaflet connecting member 131 comprises a double row hole structure, and each row of holes of the double row hole structure may include at least one non-closed hole. Each row of holes of the leaflet connecting member 131 is aligned in the axial direction of the support member 132. Wherein the axial direction is a direction extending along both ends of the support part 132 of the leaflet fixing structure 13.
It is to be understood that the non-closed hole in the embodiment of the present invention refers to a through hole having a notch on a side of a side wall, and the notch opens toward a side of the leaflet-connecting member remote from the support member.
In this embodiment, each of the holes of the leaflet attachment member 131 is a non-closed hole that penetrates through the leaflet attachment member 131, and the indentations of the two rows of holes are disposed opposite to each other and open the edge of the leaflet attachment member 131. Under the condition that the size of the leaflet connecting component is the same, compared with the condition that the closed hole is arranged on the leaflet fixing structure in the prior art, the method for connecting the leaflet with the stent has the advantages that the non-closed hole arranged on the leaflet fixing structure 13 can realize the arrangement of suture holes with more quantity and more compact distribution, so that the connecting points of the leaflet and the stent are increased, and the connecting strength of the leaflet and the stent is enhanced under the condition that the profile of the stent is not increased. Subject to the state of the art, the minimum size of a closed aperture can only be D1, whereas if a non-closed aperture is provided, the minimum size of the non-closed aperture can be much smaller than D1, thus allowing a greater number and more compact distribution of non-closed apertures to be provided on a leaflet-holding structure of the same size.
Optionally, a plurality of the leaflet connecting members 131 are circumferentially uniformly or circumferentially non-uniformly disposed along the cross-section of the stent body. For example, when there are 3 leaflet connecting members 131, an included angle between a line connecting every two adjacent leaflet connecting members 131 to a central axis of the stent body is 120 °, and it can be understood that 3 leaflet connecting members 131 are uniformly arranged in a circumferential direction of a cross section of the stent body; to match a particular cross-sectional shape of some stents, such as the D-shaped cross-section of a mitral valve stent, the included angle between the connecting lines of two adjacent leaflet connecting members 131 to the central axis of the stent body may also be set to 160 °, 100 °, in which case it is understood that 3 of the leaflet connecting members 131 are non-uniformly arranged along the circumference of the cross-section of the stent body.
Further, when each row of holes of the dual-row hole structure of the leaflet connecting member 131 includes a plurality of non-closed holes, two rows of holes of the dual-row hole structure may be symmetrically disposed along the central axis of the support member 132.
Further, the aperture size of each hole in the double-row hole structure in the axial direction is matched with the contact height required by two adjacent valve leaflets in the axial direction, and/or the number of each row of holes in the double-row hole structure is matched with the contact height required by two adjacent valve leaflets in the axial direction. Specifically, the size of the hole diameter of each hole in the axial direction, the number of holes in each row, and the axial distance between adjacent holes together determine the required contact height of two adjacent leaflets in the axial direction.
Preferably, the aperture of each hole in the double-row hole structure in the axial direction may range from 0.6mm to 5mm, and the number of each row of holes in the double-row hole structure may range from 1 to 4. Furthermore, the whole height of the double-row hole structure along the axial direction can be in a range of 2.5-5 mm.
In this embodiment, because the number of each row of holes in the double-row hole structure and the size of each hole in the axial direction can be designed to different numbers and sizes according to different actual requirements, the contact height of two adjacent valve leaflets in the heart valve prosthesis in the axial direction can be properly adjusted (usually, the contact height is extended) according to the actual requirements, and the problem of high difficulty in closing the valve leaflets is solved. In addition, the non-closed double-row hole structure of the leaflet connecting part 141 can further reduce the volume of each leaflet connecting part, thereby being beneficial to reducing the radial diameter of the heart valve prosthesis after being crimped, and being more suitable for the engineering design of the stent.
Optionally, with continued reference to fig. 4, and with reference to fig. 3 and 1, the joining region 4 of two adjacent leaflets 3 is sewn to the leaflet attachment structure 131 so that the heart valve is fixedly disposed on the inner surface of the stent body.
In this embodiment, the joining region 4 of the adjacent valve leaflet 3 is sewn to the leaflet connecting portion 131 of the stent body, thereby achieving stable fixation of the adjacent two valve leaflets. Therefore, it is preferable that the number of the leaflet fixing structures 13 is the same as the number of leaflets included in the heart valve disposed on the stent body. And, the central axis of each leaflet securing structure 13 coincides with or is parallel to the axis of the coaptation region 4 between adjacent leaflets.
Alternatively, when each hole of the leaflet-connecting member 131 is a non-closed hole penetrating the leaflet-connecting member 131 and having a notch at one side, a suture thread for suturing the bonding area of the adjacent two leaflets 3 to the leaflet-connecting member 131 is inlaid in the notch of the leaflet-connecting structure 131.
In summary, in the heart valve prosthesis provided by the present invention, under the condition that the size of the leaflet connecting component is the same, compared with the closed hole arranged on the leaflet fixing structure in the prior art, the embodiment of the present invention arranges the leaflet connecting components of the double-row hole structure in which each row of holes at least includes one non-closed hole in the stent main body in the heart valve prosthesis, so that a larger number of suture holes with more compact distribution can be arranged on the leaflet fixing structure, the connecting points of the leaflets and the stent are increased, the connecting strength between the leaflets and the stent is enhanced without increasing the outer diameter of the stent after compression, and the stability of the heart valve prosthesis in the working state is further improved.
It should be noted that, although the present invention has been described with reference to the preferred embodiments, the present invention is not limited to the embodiments. It will be apparent to those skilled in the art from this disclosure that many changes and modifications can be made, or equivalents modified, in the embodiments of the invention without departing from the scope of the invention. Therefore, any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention will still fall within the protection scope of the technical solution of the present invention.
It should be further understood that the terms "first," "second," "third," and the like in the description are used for distinguishing between various components, elements, steps, and the like, and are not intended to imply a logical or sequential relationship between various components, elements, steps, or the like, unless otherwise indicated or indicated.
It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention. It must be noted that, as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. For example, reference to "a step" or "an apparatus" means a reference to one or more steps or apparatuses and may include sub-steps as well as sub-apparatuses. All conjunctions used should be understood in the broadest sense. And, the word "or" should be understood to have the definition of a logical "or" rather than the definition of a logical "exclusive or" unless the context clearly dictates otherwise. Further, implementation of the methods and/or apparatus of embodiments of the present invention may include performing the selected task manually, automatically, or in combination.
Claims (12)
1. A heart valve prosthesis comprises a support main body and at least two valve leaflets connected to the support main body, wherein the support main body comprises grid-shaped structural units connected with each other from an inflow end to an outflow end, the heart valve prosthesis is characterized in that the support main body further comprises a plurality of valve leaflet fixing structures used for connecting the support main body and the valve leaflets, each valve leaflet fixing structure comprises a support component and a valve leaflet connecting component positioned on two sides of the support component, each valve leaflet connecting component comprises a double-row hole structure, and each row of holes in the double-row hole structure at least comprise one non-closed hole.
2. The heart valve prosthesis of claim 1, wherein the leaflet securing structure is disposed at an outflow end of the stent body or on an outer surface along a circumference of the stent body.
3. The heart valve prosthesis of claim 1, wherein the leaflet attachment members are uniformly circumferentially disposed along a cross-section of the stent body.
4. The heart valve prosthesis of claim 1, wherein when each row of holes in the double row of holes structure comprises a plurality of non-closed holes, the two rows of holes in the double row of holes structure are symmetrically disposed along the central axis of the support member.
5. The heart valve prosthesis of claim 1, wherein each aperture in the dual-row aperture structure has a size in the axial direction that is compatible with a desired contact height in the axial direction for two adjacent leaflets, and/or wherein each row of apertures in the dual-row aperture structure has a number that is compatible with a desired contact height in the axial direction for two adjacent leaflets.
6. The heart valve prosthesis of claim 5, wherein the pore diameter of each pore in the double row of pores structure in the axial direction ranges from 0.6mm to 2 mm.
7. The heart valve prosthesis of claim 5, wherein the number of holes in each row of the double row of holes structure is 1-4.
8. The heart valve prosthesis of claim 1, wherein the number of leaflet securing structures is the same as the number of leaflets.
9. The heart valve prosthesis of claim 2, wherein the leaflet securing structure is angled toward an axial direction of the stent body such that the leaflet securing structure forms a predetermined angle with a central axis of the stent body when the leaflet securing structure is disposed at the outflow end of the stent body.
10. The heart valve prosthesis of claim 9, wherein the predetermined angle is in a range of 0 ° to 15 °.
11. The heart valve prosthesis of any one of claims 1-10, wherein the bonding regions of adjacent leaflets of the leaflet are sewn to the leaflet connecting member to connect the leaflet to the stent body.
12. The heart valve prosthesis of claim 11, wherein when each of the holes of the leaflet-connecting member is a non-closed hole penetrating the leaflet-connecting member and having a notch at one side, a suture for suturing the bonding region of the adjacent two leaflets to the leaflet-connecting member is fitted in the notch of the leaflet-connecting member.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011611922.8A CN114681135A (en) | 2020-12-30 | 2020-12-30 | Heart valve prosthesis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011611922.8A CN114681135A (en) | 2020-12-30 | 2020-12-30 | Heart valve prosthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114681135A true CN114681135A (en) | 2022-07-01 |
Family
ID=82132869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011611922.8A Pending CN114681135A (en) | 2020-12-30 | 2020-12-30 | Heart valve prosthesis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114681135A (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110098800A1 (en) * | 2008-07-15 | 2011-04-28 | St. Jude Medical, Inc | Axially anchoring collapsible and re-expandable prosthetic heart valves for various disease states |
US20180289475A1 (en) * | 2012-12-31 | 2018-10-11 | Edwards Lifesciences Corporation | One-piece heart valve stents adapted for post-implant expansion |
CN109394393A (en) * | 2017-08-18 | 2019-03-01 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
CN110123490A (en) * | 2019-04-08 | 2019-08-16 | 北京佰仁医疗科技股份有限公司 | The intervention pulmonary valve and intervention aorta petal of a kind of bracket and the connection structure and application of the leaflet connection structure |
CN210301307U (en) * | 2019-03-22 | 2020-04-14 | 上海微创心通医疗科技有限公司 | Heart valve support and prosthesis thereof |
CN111035473A (en) * | 2018-10-15 | 2020-04-21 | 上海微创心通医疗科技有限公司 | Artificial heart valve prosthesis and stent thereof |
US20200188097A1 (en) * | 2018-12-12 | 2020-06-18 | Vdyne, Llc | Compressible Bileaflet Frame for Side Delivered Transcatheter Heart Valve |
CN111329623A (en) * | 2020-03-05 | 2020-06-26 | 杭州金杭齐医疗科技有限公司 | Intervention type artificial heart valve |
CN211485096U (en) * | 2019-11-22 | 2020-09-15 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
CN215937813U (en) * | 2020-12-30 | 2022-03-04 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
-
2020
- 2020-12-30 CN CN202011611922.8A patent/CN114681135A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110098800A1 (en) * | 2008-07-15 | 2011-04-28 | St. Jude Medical, Inc | Axially anchoring collapsible and re-expandable prosthetic heart valves for various disease states |
US20180289475A1 (en) * | 2012-12-31 | 2018-10-11 | Edwards Lifesciences Corporation | One-piece heart valve stents adapted for post-implant expansion |
CN109394393A (en) * | 2017-08-18 | 2019-03-01 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
CN111035473A (en) * | 2018-10-15 | 2020-04-21 | 上海微创心通医疗科技有限公司 | Artificial heart valve prosthesis and stent thereof |
US20200188097A1 (en) * | 2018-12-12 | 2020-06-18 | Vdyne, Llc | Compressible Bileaflet Frame for Side Delivered Transcatheter Heart Valve |
CN210301307U (en) * | 2019-03-22 | 2020-04-14 | 上海微创心通医疗科技有限公司 | Heart valve support and prosthesis thereof |
CN110123490A (en) * | 2019-04-08 | 2019-08-16 | 北京佰仁医疗科技股份有限公司 | The intervention pulmonary valve and intervention aorta petal of a kind of bracket and the connection structure and application of the leaflet connection structure |
CN211485096U (en) * | 2019-11-22 | 2020-09-15 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
CN111329623A (en) * | 2020-03-05 | 2020-06-26 | 杭州金杭齐医疗科技有限公司 | Intervention type artificial heart valve |
CN215937813U (en) * | 2020-12-30 | 2022-03-04 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11534295B2 (en) | Stented heart valve devices and methods for atrioventricular valve replacement | |
US10548723B2 (en) | Prosthetic heart valve devices and methods of valve replacement | |
US10245142B2 (en) | Multiple orifice implantable heart valve and methods of implantation | |
EP2861186B1 (en) | Replacement heart valve | |
JP5685183B2 (en) | Heart valve device with stent | |
EP2856972A1 (en) | Artificial heart valve | |
CN111035473A (en) | Artificial heart valve prosthesis and stent thereof | |
US11399933B2 (en) | Cardiac valve prosthesis and stent thereof | |
CN111772879A (en) | Artificial heart valve | |
CN215937813U (en) | Heart valve prosthesis | |
CN113081394B (en) | Artificial heart valve | |
CN211485096U (en) | Heart valve prosthesis | |
CN111772878A (en) | Heart valve prosthesis | |
CN217430265U (en) | Valve prosthesis | |
CN215937817U (en) | Artificial valve device capable of being intervened and replaced | |
CN114681135A (en) | Heart valve prosthesis | |
CN212395131U (en) | Artificial heart valve | |
CN212395132U (en) | Heart valve prosthesis | |
CN219354275U (en) | Valve repair device and system | |
WO2022012011A1 (en) | Prosthetic heart valve | |
CN113813085A (en) | Medical artificial valve assembly | |
WO2023144673A1 (en) | Valve skirts for prosthetic devices | |
CN116999208A (en) | valve prosthesis | |
CN112826637A (en) | Heart valve prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |